The average one-year price target for Minerva Neurosciences (NasdaqCM:NERV) has been revised to $4.08 / share. This is a decrease of 20.00% from the prior estimate of $5.10 dated July 15, 2025. The ...

Yesterday we discussed the recent report that the Phillies could be fits for the Angels’ Jo Adell and Taylor Ward. We started with breaking down Adell’s profile and the possibility he could be the ...

The United States increased pressure on Venezuela over the weekend, saying it will designate Cartel de los Soles as a foreign ...

The NHS waiting list has fallen in last 12 months under Labour for the first in 15 years - but patient demand means the ...

Economic expansion is underpinned by sustained domestic demand and stronger net exports, says the country’s chief ...

Highlights Drill hole CS25-065 encountered five (5) spodumene pegmatite intervals, with the widest continuous interval of 179 ...

“Godongwana is expected to confirm a lower inflation anchor of 3%, replacing the current 4.5% midpoint of the South African Reserve Bank’s 3%-6% target band,” Bloomberg Economics Africa Economist ...

Basically, 'Vision 2030' is the company's their medium-term plan to remain relevant in the market. And, to be concise, these ...

The 38-year-old tennis player is facing intense pressure after siding with students in their fight against both corruption ...

Modest expansion masks a deep shift as Europe abandons an export model amid U.S. tariffs, crumbling German industry and ...

A strike by resident doctors in England could reverse a slight drop in the number of patients waiting for elective treatment ...

As seen from the table, the first week of November has given back much of the equity market’s October gains (all in the case ...